We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 26, 2022

Combined Use of Aspirin and Statin Is Associated With a Decreased Incidence of HCC

Journal of Clinical Gastroenterology


Additional Info

Journal of Clinical Gastroenterology
Combined Use of Aspirin and Statin is Associated With a Decreased Incidence of Hepatocellular Carcinoma
J. Clin. Gastroenterol. 2022 Apr 01;56(4)369-373, J Singh, A Wozniak, SJ Cotler, A Dhanarajan, D Aldrich, D Park, C Kasia, B Schmidt, S Scaglione

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading